Oxaliplatin

Drug ingredient

CAS 61825-94-3

This chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.

Molecular structure of 61825-94-3 — 1 Pt²⁺

US productionNot reported

Import value, 2024$111M

Top sourceJapan 43%

This chemical is not on EPA’s Toxic Substances Control Act inventory, the list behind EPA’s production survey.

Why supply is unknown

Production is reported production, not a complete census of factories. Import value and source-country shares describe a shared customs category, not a separate chemical measurement.

Where It Comes From

Customs basis: HS 284390 · basket

These shares come from HS customs code 284390, which covers 65 tracked chemicals in total. They estimate the category's origin mix, not this chemical specifically.

Source Countries

Country of origin for US imports, from Census customs data (2024).

JP 43%JapanZA 22%South AfricaDE 12%GermanyIN 10%IndiaAR 6%Argentina

Belgium
Australia
Switzerland
Turkey
Austria
Mexico
Latvia
South Korea
Romania
Taiwan
Poland

25 FDA-registered drug labelers

Accord Healthcare Inc.

Apotex Corp.

Baxter Healthcare Corporation

BluePoint Laboratories

Camber Pharmaceuticals, Inc.

Eugia US LLC

FOSUN PHARMA USA INC.

Fresenius Kabi USA, LLC

Gland Pharma Limited

Heraeus Precious Metals GmbH & Co. KG

Hetero Labs Limited

Hospira, Inc.

Jiangsu Hengrui Pharmaceuticals Co., Ltd.

Meitheal Pharmaceuticals Inc.

Mylan Institutional LLC

NorthStar Rx LLC

Qilu Pharmaceutical Co. Ltd.

Sagent Pharmaceuticals

Sandoz Inc

SHILPA PHARMA LIFESCIENCES LIMITED

Sicor de Mexico S.A. de C.V

SUN PHARMACEUTICAL INDUSTRIES, INC.

Umicore Argentina S.A.

Veranova, L.P.

Winthrop U.S, a business of sanofi-aventis U.S. LLC

Why It Matters

Sectors

Health

Downstream Uses

Appears in 1 drug and cosmetic product listings (FDA).

•Oxaliplatin

FDA Shortage Status

Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."

No Shortage

Shortage History

Rows group FDA shortage filings by drug product. Each manufacturer makes its own FDA shortage filing, so one product can carry several reports at once: Available, Limited Availability, Unavailable or to be discontinued.

to be discontinued
Oxaliplatin Injection
Shortage listed since October 20, 2025

See all current drug shortages

Chemical Identity

CAS61825-94-3

PubChem CID9887053

DTXSIDDTXSID0036760

FormulaC8H14N2O4Pt

Mol. Weight397.29 g/mol

SMILESC1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]

Data Sources

PubChem · compound 9887053Retrieved 2026-04-07
FDA National Drug Code directoryRetrieved 2026-04-25
FDA Drug ShortagesRetrieved 2026-10-04
US Census international tradeReporting year: 2024 · Retrieved 2026-10-04

← Back to Dashboard ← Back to Health

Brief citations

Oxaliplatin (CAS 61825-94-3) https://chemicalindependence.com/chemical/61825-94-3/ PubChem: 9887053. Retrieved 2026-04-07. https://pubchem.ncbi.nlm.nih.gov/compound/9887053 FDA National Drug Code directory: CAS 61825-94-3. Retrieved 2026-04-25. https://open.fda.gov/data/ndc/ FDA Drug Shortages: CAS 61825-94-3. Retrieved 2026-10-04. https://www.accessdata.fda.gov/scripts/drugshortages/ US Census international trade: HS 284390 for CAS 61825-94-3. Reporting year: 2024. https://usatrade.census.gov/